Clinical trial
Genetics of EGFR Mutation Study (GEM): a Translational Study of the EORTC Lung Group.
NCT01838577 is registered in ClinicalTrials.gov with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetics of EGFR Mutation Study (GEM): a Translational Study of the EORTC Lung Group.
- Lead sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 30, 2013
- Completion date
- March 31, 2022
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
egfr mutation positive non small cell lung cancer